Two pieces of news provide a flicker of hope amid the doom and gloom.
Research and Markets has announced the addition of the "Clinical Decision Support System (CDSS) Market Forecasts & Opportunities 2014- 2018" report to its offerings.
In a release, Research and Markets noted that report highlights include:
The global market is expected to reach $558 million by 2018, growing at a CAGR of 10.4 percent during the forecast period (2013 to 2018).
The global clinical decision support system market is dominated by Meditech (U.S.), followed by Zynx Health (U.S.), Cerner Corp. (U.S.), McKesson Corp. (U.S.), and EPIC (U.S.).
Countries across the globe are struggling to combat issues such as escalating healthcare costs, poor or inconsistent quality of healthcare, rapid expansion in healthcare insurance, and changing healthcare reform mandates. These are further exacerbated by growing consumerism, globalization, changing demographics and lifestyles, and growing incidences of diseases that are expensive to treat. Resolving these issues is a daunting task faced by healthcare stakeholders, highlighting the need for proactive, collaborative, and systemic models. Several initiatives and healthcare reforms have been developed in order to support the adoption and implementation of CDSS solutions.
Integrated EHR solution with CDSS and CPOE is estimated to be a high growth segment over the next five years. The high growth in this segment can be attributed to the growing demand for integrated CDSS with EHR and CPOE, as it meets all the needs of clinicians, from retrieving patient data to triggering alerts and reminders. Furthermore, this system helps to reduce the number of cases of medication errors.
-Drug Allergy Alerts
-Medical Information Technology, Inc. (Meditech)
-Wolters Kluwer Health
((Comments on this story may be sent to firstname.lastname@example.org))